These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22391882)

  • 1. Obesity is a strong determinant of hypertensive target organ damage in young-to-middle-age patients.
    Palatini P; Saladini F; Mos L; Benetti E; Bortolazzi A; Cozzio S; Casiglia E
    Int J Obes (Lond); 2013 Feb; 37(2):224-9. PubMed ID: 22391882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premenopausal women have increased risk of hypertensive target organ damage compared with men of similar age.
    Palatini P; Mos L; Santonastaso M; Saladini F; Benetti E; Mormino P; Bortolazzi A; Cozzio S
    J Womens Health (Larchmt); 2011 Aug; 20(8):1175-81. PubMed ID: 21702688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension.
    Stergiou GS; Argyraki KK; Moyssakis I; Mastorantonakis SE; Achimastos AD; Karamanos VG; Roussias LG
    Am J Hypertens; 2007 Jun; 20(6):616-21. PubMed ID: 17531917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of overweight and obesity on cardiac benefit of antihypertensive treatment.
    Gerdts E; de Simone G; Lund BP; Okin PM; Wachtell K; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    Nutr Metab Cardiovasc Dis; 2013 Feb; 23(2):122-9. PubMed ID: 21775111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients.
    Cuspidi C; Meani S; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
    J Hum Hypertens; 2005 Jun; 19(6):471-7. PubMed ID: 15744331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central blood pressure is an independent predictor of future hypertension in young to middle-aged stage 1 hypertensives.
    Saladini F; Mos L; Casiglia E; Malipiero G; Mazzer A; Palatini P
    Blood Press; 2013 Feb; 22(1):9-16. PubMed ID: 23004344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
    Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
    Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From treatment to organ damage; a 5-year follow-up study of ambulatory blood pressure in essential hypertension. Diversity between development of left ventricular hypertrophy and urinary albumin excretion.
    Stenehjem AE; Bjørnerheim R; Os I
    Blood Press; 2007; 16(2):87-94. PubMed ID: 17612906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sex differences in the correlation between obesity and hypertension with left ventricular mass and hypertrophy].
    Kuch B; Muscholl M; Luchner A; Döring A; Riegger GA; Schunkert H; Hense HW
    Z Kardiol; 1996 May; 85(5):334-42. PubMed ID: 8711946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of central and general adiposity to abnormal left ventricular diastolic function in a community sample with a high prevalence of obesity.
    Libhaber CD; Norton GR; Majane OH; Libhaber E; Essop MR; Brooksbank R; Maseko M; Woodiwiss AJ
    Am J Cardiol; 2009 Dec; 104(11):1527-33. PubMed ID: 19932787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
    Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM
    Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular permeability, blood pressure, and organ damage in primary hypertension.
    Viazzi F; Leoncini G; Ratto E; Parodi A; Falqui V; Conti N; Tomolillo C; Ravera G; Deferrari G; Pontremoli R
    Hypertens Res; 2008 May; 31(5):873-9. PubMed ID: 18712042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of renal resistive index with target organ damage in essential hypertension.
    Doi Y; Iwashima Y; Yoshihara F; Kamide K; Takata H; Fujii T; Kubota Y; Nakamura S; Horio T; Kawano Y
    Am J Hypertens; 2012 Dec; 25(12):1292-8. PubMed ID: 22874890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure load, vascular permeability and target organ damage in primary hypertension.
    Falqui V; Viazzi F; Leoncini G; Ratto E; Parodi A; Conti N; Tomolillo C; Deferrari G; Pontremoli R
    J Nephrol; 2007; 20 Suppl 12():S63-7. PubMed ID: 18050146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of target organ damage by different values of self-blood pressure measurement in untreated hypertensive patients.
    Coll-de-Tuero G; Saez M; Roca-Saumell C; Rodriguez-Poncelas A; Franco P; Dalfó A; Calvó-Perxas L; Pose-Reino A; Bayó-Llibre J
    Am J Hypertens; 2012 Dec; 25(12):1256-63. PubMed ID: 22914254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resting heart rate as a predictor of body weight gain in the early stage of hypertension.
    Palatini P; Mos L; Santonastaso M; Zanatta N; Mormino P; Saladini F; Bortolazzi A; Cozzio S; Garavelli G;
    Obesity (Silver Spring); 2011 Mar; 19(3):618-23. PubMed ID: 20814417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study.
    Olsen MH; Wachtell K; Ibsen H; Lindholm LH; Dahlöf B; Devereux RB; Kjeldsen SE; Oikarinen L; Okin PM;
    J Hypertens; 2006 Apr; 24(4):775-81. PubMed ID: 16531808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?
    Verdecchia P; Angeli F; Gattobigio R; Guerrieri M; Benemio G; Porcellati C
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S23-8. PubMed ID: 15592569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.